NPI registry status
Active
2026 NPPES data Otolaryngology Physician NPI 1912978057 M.D.
Verify on CMS → John Grosso, M.D.
Otolaryngology Physician in Lindenhurst, New York.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 11,060 in Otolaryngology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
767
Medicare Part D claims · 347 beneficiaries · Otolaryngology Physician avg: 536
Generic prescribing
97%
generic claims · 3% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
87.2/100
▲ 4 pts above national avg 83.5 · Above neutral
Industry payments
$171.82
2 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
John Grosso, M.D. reported a CMS MIPS final score of 87.2/100 - above the 83.5 national average - and filed 767 Medicare Part D claims in 2024.
- 87.2/100
- MIPS score · +4 vs avg
- 767
- Part D claims, 2024
- 97%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about John Grosso, M.D.
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1912978057), first enumerated 01/27/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 767 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 87.2/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$171.82 in reported industry payments (2 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- State context
State board disciplinary context
New York statewide board action statistics are published annually — these figures describe aggregate state activity, not John Grosso, M.D.'s individual license status. Verify directly with the state medical board.
Source: NYSBPMC annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1912978057 · Otolaryngology Physician
NPI-10 · ENUM-LEGACY · TAX-MID · MIPS-ABOVE · RX-LIGHT · BOOK-LIGHT · PHOTO-FINISH
- NPI-10 1912978057
- ENUM-LEGACY 2006
- TAX-MID 11K Otolaryngology Physician
- MIPS-ABOVE 87.2/100
- RX-LIGHT 767
- BOOK-LIGHT 724 in New York
- PHOTO-FINISH Hassen Mohammed, M.D. · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Grosso · this pr…
Grosso · this provider
87.2 MIPS pts
- Hassen Mohammed,…
Hassen Mohammed, M.D.
87.2 MIPS pts
- Alexa Castellano…
Alexa Castellano, MD
87.2 MIPS pts
- William Starr, M…
William Starr, M.D.
87.2 MIPS pts
- Jason Acevedo, M…
Jason Acevedo, MD
87.3 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
John Grosso, M.D.'s MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
87 ≥ 52nd percentile 52% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where John Grosso, M.D. sits
This provider among otolaryngology physician peers
Across the 3,290 otolaryngology physician providers who report both Medicare Part D prescribing and a MIPS quality score, John Grosso, M.D. writes more Part D claims than 73% of them and scores higher on MIPS quality than 57% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one otolaryngology physician peer from a representative sample of 60; the gold marker is John Grosso, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
John Grosso, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about John Grosso, M.D.?
High performer (top quartile)Primary specialty
Otolaryngology Physician
Medicare Part D claims
767 43% vs specialty avg
MIPS final score
87.2/100 3.7 pts vs avg
Specialty distribution in New York
How Otolaryngology Physician compares to other specialties among New York providers
Medicare quality performance, MIPS
John Grosso, M.D.'s 2023 MIPS final score plotted against the Otolaryngology Physician national average
- MIPS Final Score
- 87.2/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1912978057 |
|---|---|
| Specialty | Otolaryngology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 01/27/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
87.2106
Final Score
Measured-score avg: 83.5
74.4213
Quality
Reporting: Group practice
Hospital and facility affiliations
Facilities where John Grosso, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Sunrise Ent PC
Lindenhurst, NY
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for John Grosso, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$172
Largest payer
Genentech USA, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - New York NYSBPMC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 - they are NOT specific to John Grosso, M.D.. To verify John Grosso, M.D.'s current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases
NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Generic-heavy
John Grosso, M.D. - brand share 3.0%
Otolaryngology Physician average
3% brand-name claims vs 97% generic, on 767 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
767
Total Claims
$16K
Total Drug Cost
347
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 1,115.333
- Total Day Supply
- 27,310
- Brand vs Generic
- 3% brand / 97% generic
- Brand Drug Cost
- $1K
- Generic Drug Cost
- $15K
- Opioid Claims
- 11 (1.4% rate)
- Antibiotic Claims
- 83
Patient Demographics
- Average Patient Age
- 74.3 years
- Avg HCC Risk Score
- 1.21
- Gender Split
- 59% female / 41% male
- Age Distribution
- <65: 30, 65-74: 148, 75-84: 121, 85+: 48
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What John Grosso, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Fluticasone Propio…
Fluticasone Propionate
153 claims
- Ipratropium Bromide
Ipratropium Bromide
103 claims
- Neomycin-Polymyxin…
Neomycin-Polymyxin-Hc
103 claims
- Montelukast Sodium
Montelukast Sodium
69 claims
- Prednisone
Prednisone
68 claims
- Clotrimazole-Betam… 40
Clotrimazole-Betamethasone
40 claims
- Mometasone Furoate 21
Mometasone Furoate
21 claims
- Cefdinir 19
Cefdinir
19 claims
| Drug | Claims |
|---|---|
| Fluticasone Propionate | 153 |
| Ipratropium Bromide | 103 |
| Neomycin-Polymyxin-Hc Neomycin/Polymyxin B/Hydrocort | 103 |
| Montelukast Sodium | 69 |
| Prednisone | 68 |
| Clotrimazole-Betamethasone Clotrimazole/Betamethasone Dip | 40 |
| Mometasone Furoate | 21 |
| Cefdinir | 19 |
| Omeprazole | 17 |
| Triamterene-Hydrochlorothiazid Triamterene/Hydrochlorothiazid | 16 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Otolaryngology Physician Overview
How John Grosso, M.D. fits within the Otolaryngology Physician landscape nationally.
11,060
Otolaryngology Physician Providers in US
54
States with Otolaryngology Physician
536
Avg Claims per Provider
John Grosso, M.D.'s 767 claims are above the specialty average of 536.
Nationwide Otolaryngology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Grosso, both outside New York so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (87.2 here).
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Otolaryngology Physician Providers in New York
Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as Grosso.
One of 724 Otolaryngology Physician providers enrolled in New York, 5 are shown here.
Dr. Michel Abboud
MD
New York, NY
Dr. Allan Abramson
MD
New Hyde Park, NY
Sara Abu Ghanem
Brooklyn, NY
Dr. Benjamin Acker
D.O.
Port Jefferson Station, NY
Dr. Kayla Ackerman
MD
Oneida, NY
Compare Otolaryngology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is John Grosso, M.D.'s specialty? ▼
John Grosso, M.D. specializes in Otolaryngology Physician and practices in Lindenhurst, New York. Credentials: M.D..
How much does John Grosso, M.D. prescribe under Medicare Part D? ▼
In 2024, John Grosso, M.D. wrote 767 Medicare Part D claims totaling $16K in drug costs for 347 beneficiaries.
What is John Grosso, M.D.'s Medicare quality score? ▼
John Grosso, M.D. has a CMS MIPS Final Score of 87.2/100 (Quality: 74.4). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is John Grosso, M.D. located? ▼
John Grosso, M.D. is located at 100 SUNRISE HWY, Lindenhurst, NY, 11757. Phone: (631) 226-1800.
What is John Grosso, M.D.'s NPI number? ▼
John Grosso, M.D.'s National Provider Identifier (NPI) is 1912978057, issued on 01/27/2006.
Does John Grosso, M.D. prescribe more brand-name or generic drugs? ▼
John Grosso, M.D.'s prescribing is 3% brand-name and 97% generic drugs by claim count, with $1K in brand drug costs.
Does John Grosso, M.D. prescribe opioids? ▼
Yes, John Grosso, M.D. had 11 opioid claims in 2024 with an opioid prescribing rate of 1.4%.
How many Otolaryngology Physician providers are there in the US? ▼
There are 11,060 Otolaryngology Physician providers across 54 states in the US. The average Otolaryngology Physician provider writes 536 Medicare Part D claims per year.
What drugs does John Grosso, M.D. prescribe most often? ▼
Based on 2024 Medicare Part D data, John Grosso, M.D.'s most frequently prescribed drugs include Fluticasone Propionate, Ipratropium Bromide, Neomycin-Polymyxin-Hc. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does John Grosso, M.D. accept Medicare? ▼
John Grosso, M.D. appears in CMS Medicare data with 767 Part D claims and 347 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify John Grosso, M.D.'s credentials? ▼
John Grosso, M.D.'s NPI is 1912978057 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.